(PTCT) PTC Therapeutics - Performance 55.9% in 12m
PTCT performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
2.34%
#32 in Peer-Group
Rel. Strength
86.90%
#974 in Stock-Universe
Total Return 12m
55.89%
#22 in Peer-Group
Total Return 5y
-10.14%
#37 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 7.71 |
| P/E Forward | 6.26 |
| High / Low | USD |
|---|---|
| 52 Week High | 57.17 USD |
| 52 Week Low | 30.39 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 19.63 |
| Buy/Sell Signal +-5 | -0.75 |
| Support / Resistance | Levels |
|---|---|
| Support | 48.3, 35.4 |
| Resistance | 55.3 |
12m Total Return: PTCT (55.9%) vs XBI (-10.7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.32% | 68% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-10.6% | -8.81% | 144% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.71% | -3.57% | 32.5% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.36% | 31.7% | -6.18% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.76% | -8.64% | 0.27% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.5% | 65.3% | -5.65% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
-0.49% | 55.9% | -10.1% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.44% | 35.3% | 14.7% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: PTCT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for PTCT
| Total Return (including Dividends) | PTCT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -0.49% | 2.27% | 4.52% |
| 3 Months | 4.27% | 6.30% | 10.43% |
| 12 Months | 55.89% | -10.68% | 14.67% |
| 5 Years | -10.14% | -26.13% | 109.23% |
| Trend Score (consistency of price movement) | PTCT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -58.8% | 5.5% | 79.1% |
| 3 Months | 59.5% | 74.3% | 94.2% |
| 12 Months | 82% | -84.7% | 44.4% |
| 5 Years | -31.8% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th55.00 | -2.70% | -4.79% |
| 3 Month | %th50.50 | -1.91% | -5.58% |
| 12 Month | %th90.00 | 74.52% | 35.94% |
| 5 Years | %th82.00 | 21.65% | -57.05% |
FAQs
Does PTC Therapeutics (PTCT) outperform the market?
Yes,
over the last 12 months PTCT made 55.89%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.68%.
Over the last 3 months PTCT made 4.27%, while XBI made 6.30%.
Performance Comparison PTCT vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
PTCT vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3.9% | -5% | -0.4% | 41% |
| US NASDAQ 100 | QQQ | -3.4% | -5.2% | -1.6% | 42% |
| German DAX 40 | DAX | -2.2% | 0.6% | -11.8% | 27% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2.9% | -4.7% | -1.3% | 38% |
| Hongkong Hang Seng | HSI | -2.1% | -6.6% | -18.1% | 20% |
| India NIFTY 50 | INDA | -4% | -2.9% | 1.3% | 56% |
| Brasil Bovespa | EWZ | -5% | -8% | -23.2% | 43% |
PTCT vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -4.5% | -6.5% | -5.5% | 28% |
| Consumer Discretionary | XLY | -3.3% | -2.6% | 6.9% | 36% |
| Consumer Staples | XLP | -2.9% | -0.1% | 0% | 45% |
| Energy | XLE | -2.7% | -4.8% | 5.7% | 59% |
| Financial | XLF | -4.2% | -4.1% | -4.1% | 26% |
| Health Care | XLV | -4.3% | -4% | 5.7% | 60% |
| Industrial | XLI | -4.1% | -4.6% | -7.5% | 31% |
| Materials | XLB | -4.8% | -4.7% | -3.4% | 50% |
| Real Estate | XLRE | -0.8% | -1.2% | 0.8% | 43% |
| Technology | XLK | -3.6% | -8.4% | -2.7% | 45% |
| Utilities | XLU | -2.5% | -0.9% | -3% | 31% |
| Aerospace & Defense | XAR | -4.5% | -7.7% | -18.8% | 7% |
| Biotech | XBI | -1.2% | -2.8% | 15.1% | 67% |
| Homebuilder | XHB | -6.4% | -11% | 6.2% | 51% |
| Retail | XRT | -4.9% | -5% | 5.4% | 47% |
PTCT vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -3.4% | -6.79% | 9.81% | 65% |
| Natural Gas | UNG | 4.9% | 9.9% | 17.1% | 65% |
| Gold | GLD | -2.5% | 0.8% | -19.4% | 13% |
| Silver | SLV | -2.5% | -4.1% | -15.6% | 34% |
| Copper | CPER | -5% | -4.4% | -18.8% | 41% |
PTCT vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -2.9% | -4% | 3.5% | 54% |
| iShares High Yield Corp. Bond | HYG | -2.1% | -1.7% | 1.8% | 46% |